Johnson & Johnson Innovation – JJDC, Inc., the venture capital arm of Johnson & Johnson, has made a US$15 million commitment to Vivo Capital, a private equity firm focused on investing in and developing healthcare companies in the U.S. and China, according to a company announcement. The Vivo Capital Fund VIII, which just reached a […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network